Trial Profile
ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Sivelestat (Primary)
- Indications Community-acquired pneumonia; Respiratory insufficiency
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 09 Jun 2014 New trial record